Last reviewed · How we verify
Systane Complete
At a glance
| Generic name | Systane Complete |
|---|---|
| Also known as | Experimental group |
| Sponsor | University of Alabama at Birmingham |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery (PHASE4)
- Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery (PHASE4)
- Quantifying Ocular Surface Aberrations After Tear Film Interventions (PHASE4)
- Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance (PHASE4)
- Systane® Complete Preservative Free Lubricant Eye Drops (NA)
- Artificial Tears, Tear Lipids and Tear Film Dynamics (PHASE4)
- Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease (PHASE2)
- Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |